PURE BIOSCIENCE·4

Dec 29, 7:20 PM ET

PEISER EUGENE S 4

4 · PURE BIOSCIENCE · Filed Dec 29, 2004

Insider Transaction Report

Form 4
Period: 2004-12-27
Transactions
  • Purchase

    Common

    2004-12-27+25,00078,051 total
Holdings
  • Options

    Common
    250,000
Footnotes (2)
  • [F1]Shares issued for compensation for a consulting agreement entered into in December 2004 regarding the registrant's FDA good manufacturing practices certification.
  • [F2]Previously reported Stock Option Grants, the exercise price of which has been reset to $0.50.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT